RECRUITING

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical decision support mechanisms in the electronic health record (EHR). The main question is whether electronic prompts triggered by hyperglycemia and elevated A1c results in providers providing earlier treatments and faster time to subsequent primary care appointment and greater reduction in hemoglobin A1c (HA1c). ED clinicians will receive alerts called Our Practice Advisories (OPA's) through the EPIC EHR. The 1st OPA triggers when a random point-of-care (POC) glucose is ≥250 mg/dL, prompting a suggested additional HA1c order. A 2nd OPA triggers if the resulting HA1c is ≥10%, prompting consideration of further care coordination in the Observation Unit. Investigators will compare the outcomes post-intervention compared to pre-intervention.

Official Title

Diabetes Electronic Prompt for Improved Care Coordination and Treatment (DEPICCT) in the ED

Quick Facts

Study Start:2025-03-30
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06899191

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who arrive in the emergency department
  2. * Not pregnant or peri-partum
  3. * Not SARS-COV-2 PCR positive in past 7 days
  1. * Diabetic ketoacidosis (pH \< 7.20, HCO3 \< 15, AG \> 25)
  2. * Diabetic foot ulcer or skin complications
  3. * Hyperglycemic hyperosmolar state with neurologic impairment
  4. * Patients who leave against medical advice (AMA), elope from the ED, or are transferred to another facility

Contacts and Locations

Study Contact

Paul Peng, MD PhD MS
CONTACT
732-633-1402
paul.peng@rutgers.edu

Study Locations (Sites)

Rutgers, Robert Wood Johnson Hospital
New Brunswick, New Jersey, 08901
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-30
Study Completion Date2026-03

Study Record Updates

Study Start Date2025-03-30
Study Completion Date2026-03

Terms related to this study

Keywords Provided by Researchers

  • Type 2 Diabetes
  • Electronic Prompt
  • Emergency Department Diabetes
  • Practice Advisory

Additional Relevant MeSH Terms

  • Type 2 Diabetes
  • Type 2 Diabetes Mellitus (T2DM)
  • Hyperglycemia
  • Insulin Dependent Diabetes